Group 1: CPI Analysis - November CPI year-on-year increased to 0.7%, up 0.5 percentage points from the previous value of 0.2%[1] - November food CPI month-on-month rose by 0.5%, an increase of 0.2 percentage points from the previous value[3] - Core CPI month-on-month fell to -0.3%, down 0.3 percentage points from the previous month, remaining above seasonal levels for two consecutive months[3] Group 2: PPI Insights - November PPI year-on-year decreased to -2.2%, a decline of 0.1 percentage points from the previous value of -2.1%[4] - Coal mining and washing industry PPI month-on-month increased by 4.1%, significantly up from the previous value of 1.6%[4] - Input factors and real estate chain contributed to a greater drag on PPI year-on-year, with respective contributions of -0.5 and -0.7 percentage points[4] Group 3: Future Inflation Predictions - December CPI is expected to rise to around 1.0% year-on-year, with a month-on-month increase of approximately 0.2%[6] - December PPI is anticipated to show a year-on-year increase, with the average for 2025 expected to be around -2.6%[6] - The future trajectory of PPI will depend on international commodity prices and domestic policy strength[6] Group 4: Risk Factors - Potential risks include unexpected policy changes and significant fluctuations in commodity prices[6]

Core Insights - The report highlights a rebound in export growth, with November exports increasing by 5.9% year-on-year, indicating strong resilience in foreign trade [5][7][9] - The construction sector is experiencing a divergence in performance, with traditional and new infrastructure projects working in tandem [20][23] - The automotive sector is witnessing significant growth, particularly in modular supply and die-casting businesses, with expectations of continued high profit growth [25][26] Group 1: Export and Trade Insights - November import growth was recorded at 1.9% year-on-year, while exports saw a notable increase of 5.9% year-on-year, marking a recovery from previous declines [5][6] - The trade surplus also improved, with a year-on-year increase of 14.7%, reflecting a robust trade environment [5][6] - The report emphasizes that China's export strength is driven by high cost-performance products, with machinery and high-tech products showing significant growth [8][9] Group 2: Construction Sector Analysis - The construction sector's fixed asset investment decreased by 1.7% year-on-year, with infrastructure investment growing by only 1.5%, indicating a slowdown [20][21] - Major state-owned enterprises in the construction sector reported a revenue decline of 4.4% year-on-year, highlighting the challenges faced due to reduced new contracts and prolonged payment cycles [21][22] - The report suggests focusing on opportunities in overseas construction, urban renewal, digital construction, and power engineering as key growth areas [22][23] Group 3: Automotive Sector Developments - The automotive sector is experiencing rapid growth, with the company transitioning successfully to a modular supplier, expecting significant revenue increases [25][26] - The market for stamping parts is substantial, with a domestic market size of approximately 300 billion, and the company is positioned to capture a larger market share [26][27] - The report anticipates continued high growth in the automotive sector, driven by partnerships with major automotive brands and the expansion of product offerings [27][28] Group 4: Electronics Sector Insights - The electronics sector, particularly in ODM, is set to benefit from the AI wave, with the company positioned as a leader in smartphone ODM with a revenue of 464 billion [29][30] - The report outlines a strategic focus on expanding into new growth areas such as smart glasses and automotive electronics, leveraging AI technology [30][31] - The company is expected to see significant revenue growth, with projections of 462.08 billion, 546.44 billion, and 663.31 billion for 2025-2027 [29][31]

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company has successfully transformed into a modular supplier, with its die-casting business entering a harvest period. Revenue is projected to grow significantly, with net profits expected to reach 9.32 billion, 13.34 billion, and 16.97 billion yuan from 2025 to 2027, respectively [5][61]. - The company has seen rapid revenue growth, from 800 million yuan in 2021 to an estimated 4.2 billion yuan in 2024, indicating a strong upward trajectory in the automotive structural parts sector [5][20]. - The company is positioned to become a leading player in the domestic automotive structural parts market, benefiting from the rise of domestic brands and the acceptance of integrated die-casting technology [6][61]. Summary by Sections 1. Company Overview - Founded in 2004, the company has evolved from mold manufacturing to stamping and die-casting, establishing a comprehensive production capability across various automotive components [12]. - The company has a concentrated shareholding structure, with significant ownership by its founders, which enhances management stability and operational efficiency [16]. 2. Market Potential - The stamping parts market in China is approximately 300 billion yuan, with a global market size of about 15 trillion yuan, indicating substantial growth opportunities [6]. - The integrated die-casting market is expected to exceed 10 billion yuan in 2022 and reach 100 billion yuan by 2025, driven by cost reduction and efficiency improvements [35]. 3. Competitive Advantages - The company has a strong focus on technology and management, which has led to high profitability levels. Its production strategy is based on demand-driven expansion, ensuring efficient capacity utilization [48]. - The company has established relationships with key clients, including major domestic automotive manufacturers, which are expected to drive future revenue growth [51][55]. 4. Financial Projections - Revenue is projected to grow from 2.6 billion yuan in 2023 to 11.2 billion yuan by 2027, with a compound annual growth rate (CAGR) of 66.6% from 2020 to 2024 [8][20]. - The company's net profit margin is expected to improve, with net profit projected to reach 1.7 billion yuan by 2027, reflecting a robust growth trajectory [8][61].

Investment Rating - The report suggests a focus on "innovation-driven" and "steady growth" strategies within the pharmaceutical sector, indicating a positive investment outlook for the industry [3][4]. Core Insights - The North Exchange's pharmaceutical and biotechnology sector comprises 21 companies, all classified as specialized and innovative, with a significant proportion being national and provincial champions [2][16]. - The report emphasizes the potential of innovative drugs, high-end medical devices, and robust generics as key investment areas, highlighting the importance of unique products and market share advantages [3][4]. - The medical device sector has shown the highest market value growth in 2025, with an increase of 130.47%, while traditional Chinese medicine has faced performance challenges [28][32]. Summary by Sections Industry Overview - The North Exchange's pharmaceutical sector includes five sub-sectors: traditional Chinese medicine, medical devices, medical aesthetics, biological products, and chemical pharmaceuticals [12][24]. - The average market capitalization of the 21 companies in this sector reached 3.643 billion yuan as of December 1, 2025, reflecting a year-to-date increase of 41.97% [21][23]. Sub-sector Analysis - The medical device industry led the market value growth in 2025, with a total market value increase from 6.818 billion yuan at the end of 2024 to 15.713 billion yuan by December 1, 2025 [28]. - The chemical pharmaceutical sector also performed well, with notable companies like Deyuan Pharmaceutical showing a revenue increase of 22% year-on-year in the first three quarters of 2025 [4][34]. Company Case Studies - **Innovative Drugs**: Norsland's gene therapy drug NL003 is nearing approval, targeting a significant patient population with a new treatment method [4][9]. - **Medical Devices**: Weizhu Zhiyuan focuses on smart orthopedic surgical navigation systems, emphasizing the importance of unique technology and market positioning [4][11]. - **Generics**: Deyuan Pharmaceutical is transitioning from generics to innovative drugs, with a solid historical performance and a focus on diabetes and hypertension treatments [4][34]. Performance Metrics - The report notes that the average PE TTM for the pharmaceutical sector was 32X as of December 1, 2025, with the medical device sector showing a higher valuation at 78X [15][55]. - Companies like Jinbo Biological and Norsland have seen significant stock price increases, with Jinbo's stock rising by 170.68% and Norsland by 113.10% in 2025 [41][42].

1. Report Industry Investment Rating There is no information provided regarding the report industry investment rating in the given content. 2. Core Viewpoints of the Report - The export growth rate rebounded and turned positive in November 2025, indicating strong resilience in foreign trade. The root cause of China's exports continuously exceeding expectations lies in the high cost - effectiveness of Chinese goods, which is the result of domestic "involution" and technological progress. Although the export growth rate may slow down in December due to the high base in 2024, the high cost - effectiveness of Chinese goods will remain unchanged, and China's exports will remain high for a long time. In the bond market, with the revision of economic expectations, bond yields are expected to rise trend - wise [1][5][6][7]. 3. Summary by Relevant Catalogs 3.1 11 - month Import and Export Data Highlights - In November 2025, the year - on - year growth rates of imports, exports, and trade surplus all rebounded. Exports increased by 5.9% year - on - year and 8.2% month - on - month, and the export amount reached a high level since 2021 [3][4]. 3.2 Reasons for the Rebound of Export Growth Rate in November - The negative year - on - year export growth in October was mainly due to the base dislocation in September and October 2024 and trade frictions. After the China - US talks in Kuala Lumpur and the meeting in Busan, the conclusion of trade agreements promoted the return of the export rhythm to normal. After the elimination of base disturbances, the export growth rate rebounded and turned positive in November [5]. 3.3 Analysis of Export Structure - As of November 2025, the cumulative year - on - year growth of mechanical and electrical products exports was 8.0%, and that of high - tech product exports was 6.6%, showing relatively high - speed growth. In contrast, the cumulative year - on - year decrease of labor - intensive goods was 4.2%, indicating a transformation from labor - intensive to high - tech products in exports, which may reflect China's industrial transformation and upgrading [6]. 3.4 Forecast of Export Growth Rate in December - Due to the high base caused by the rush to export in December 2024 after Trump's election and the resulting increase in trade policy uncertainty, the export growth rate in December 2025 may be under pressure. However, the high cost - effectiveness of Chinese goods will not change [7]. 3.5 Market Conditions - On December 8, the long - term yield first rose and then fell, showing an "M" - shaped trend. After the Politburo meeting mentioned the implementation of a more proactive fiscal policy and a moderately loose monetary policy, the long - term yield quickly declined. Attention should be paid to the Fed's interest rate decision and the Central Economic Work Conference [8]. 3.6 Bond Market Viewpoints - In the context of the revision of economic expectations, bond yields are expected to rise trend - wise. For stock and bond allocation, the previous views are maintained [9].

银行 2025 年 12 月 10 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -19% -10% 0% 10% 19% 29% 2024-12 2025-04 2025-08 2025-12 银行 沪深300 相关研究报告 《大行 ΔEVE 指标测算及承接债券 能力评估—行业深度报告》-2025.12.8 《存款偏离与指标问题对当前司库策 略的影响—行业深度报告》-2025.12.4 《理财投资权益的当下与未来—理财 持仓全景扫描系列（七）》-2025.11.27 测算：BCBS 调整利率冲击幅度对ΔEVE 的影响 ——行业点评报告 投资建议 （1）底仓配置：大型国有银行。受益标的农业银行、工商银行；（2）核心配置： 头部综合龙头。受益标的招商银行、兴业银行，推荐标的中信银行；（3）弹性配 置：受益标的江苏银行、重庆银行、渝农商行。 风险提示：宏观经济增速下行；债市利率大幅调整。 | 刘呈祥（分析师） | 朱晓云（分析师） | | --- | --- | | liuchengxiang@kysec.cn | zhuxiaoyun@kysec.cn | | 证书编号：S0790523060002 ...

Core Insights - The report highlights a steady recovery in AIDC demand in China, driven by significant capital expenditures from major companies like Alibaba, which reported a 34% year-on-year revenue growth in its cloud segment and an 80.1% increase in capital expenditures [35][38]. - The potential approval of the H200 chip for export to China is expected to further stimulate domestic AI model development and increase demand for domestic AIDC solutions [42][43]. Macroeconomic Overview - The macroeconomic analysis indicates a continued trend of moderate export recovery, with November exports increasing by 5.9% year-on-year, a significant rebound from the previous decline of 1.1% [6][7]. - The report notes that while there is a recovery in export figures, the overall trend remains cautious due to high base effects and potential global trade slowdowns [9][10]. Industry Analysis - The telecommunications sector is experiencing a positive shift, with AIDC demand expected to accelerate as companies ramp up investments in AI and cloud infrastructure [35][39]. - The report suggests that the approval of the H200 chip could lead to a resurgence in demand for AI servers and related infrastructure, benefiting various segments within the AIDC ecosystem [42][43]. Investment Recommendations - Recommended stocks in the AIDC space include companies like Huazhong Technology, Aofei Data, and Guanghuan New Network, which are positioned to benefit from the anticipated growth in AIDC demand [40][44]. - The report also identifies potential beneficiaries in the cooling and power supply sectors related to AIDC, suggesting a broad investment opportunity across the supply chain [40][44]. Institutional Research Trends - Recent institutional research has shown increased interest in sectors such as home appliances, building materials, and computing, indicating a shift in market focus [24][25]. - The report emphasizes the importance of institutional research as a critical component of investment decision-making, providing timely and multidimensional insights into industry dynamics [24].

Investment Rating - The industry investment rating is "Overweight" (maintained) [1] Core Insights - The report highlights strong growth in AIDC demand driven by significant capital expenditures from Alibaba, which reported a 34% year-on-year revenue increase in Q2 FY2026 and an 80.10% increase in total capital expenditures [3] - Century Internet's IDC business shows robust growth with a 21.7% year-on-year revenue increase in Q3 2025, indicating a positive trend in AIDC demand [4] - The potential approval of the H200 chip is expected to boost domestic AIDC demand, enhancing the AI ecosystem in China [5] Summary by Sections AIDC Demand and Growth - Alibaba's capital expenditures reached 31.5 billion yuan in Q2 FY2026, up 80.10% year-on-year, with a focus on AI cloud computing infrastructure [3] - Century Internet's operational capacity increased to 783 MW, with a quarterly growth of 109 MW, reflecting a strong demand for IDC services [4] Chip Supply and Market Impact - The U.S. government's potential approval for the H200 chip could significantly enhance domestic AIDC demand and support the growth of the AI ecosystem in China [5] Investment Recommendations - Recommended stocks in AIDC data centers include Guanghuan New Network, Aofei Data, and others, while beneficiaries include WanGuo Data and Century Internet [6] - For AIDC cooling solutions, recommended stocks include Yingweike, with beneficiaries like Yinlun Co. and others [6] - In AIDC power supply, beneficiary stocks include Kehua Data and others [6]

业 研 究 《"AI+卫星"的共振—行业周报》 -2025.12.7 《字节发布豆包手机助手，重视端侧 AI 投 资 机 遇 — 行 业 点 评 报 告 》 -2025.12.1 《谷歌和阿里火出圈，全球 AI 持续共 振—行业周报》-2025.11.30 蒋颖（分析师） 雷星宇（联系人） jiangying@kysec.cn ——行业点评报告 投资评级：看好（维持） 行业走势图 数据来源：聚源 -24% 0% 24% 48% 72% 96% 2024-12 2025-04 2025-08 通信 沪深300 相关研究报告 2025 年 12 月 09 日 "H200 芯片或放开"下的投资机会梳理 leixingyu@kysec.cn 证书编号：S0790124040002 英伟达 H200 芯片有望获对华出口许可，国内 AI 模型发展或将加速 2025 年 12 月 9 日，据央视网、中国基金报消息，美国总统特朗普在"真实社交" 媒体平台发文称，在确保美国国家安全的前提下，将"允许英伟达向中国及其他 国家的合格客户交付其 H200 芯片产品"，Blackwell 芯片以及即将发布的 Rubin 芯片则不在获批 ...

Group 1 - The report indicates a rebound in institutional research focus on home appliances, building materials, and computers, with an increase in the number of research sessions compared to the previous week [2][12][19] - In the weekly perspective, the total number of research sessions for the entire A-share market decreased to 482, lower than 542 in the same period of 2024, indicating a continued decline in research heat [12][20] - Monthly data shows that in November, the total number of research sessions for the entire A-share market reached 2969, which is lower than 3286 in the same period of 2024, but reflects a rebound compared to previous months [20][21] Group 2 - From an individual stock perspective, companies such as Dazhu Laser, Jereh, and Fule New Materials received significant market attention, with Dazhu Laser being researched 4 times in the last week [25][28] - Over the past month, companies like Oke Yi, Huichuan Technology, and Ice Wheel Environment have also garnered considerable attention, with Oke Yi being researched 28 times [29][30] - Zhongyou Technology, focusing on intelligent logistics systems, has seen a remarkable performance with a revenue growth of 36.69% and a net profit growth of 1074.35% in the first three quarters of 2025, leading to increased institutional interest [27]